Carlos Alban's Net Worth
$83.6 Million
Who is Carlos Alban?
Carlos Alban has an estimated net worth of $83.6 Million. This is based on reported shares across multiple companies, which include ABBOTT LABORATORIES, AbbVie Inc., SpringWorks Therapeutics, Inc., and Solventum Corp.
SEC CIK
Carlos Alban's CIK is 0001474632
Past Insider Trading and Trends
2012 was Carlos Alban's most active year for acquiring shares with 15 total transactions. Carlos Alban's most active month to acquire stocks was the month of January. 2012 was Carlos Alban's most active year for disposing of shares, totalling 20 transactions. Carlos Alban's most active month to dispose stocks was the month of January. 2020 saw Carlos Alban paying a total of $4,155,980.40 for 302,835 shares, this is the most they've acquired in one year. In 2020 Carlos Alban cashed out on 317,077 shares for a total of $19,656,853.22, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ABBOTT LABORATORIES (ABT) Snapshot price: $113.86
Senior Vice President
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +15.68% | 18.45K |
—
|
—
| 136.14K |
Nov 16 - Dec 1
| |||
Form 4
| +2.50% | 2.87K |
$69.28 | -$140,776.96 | 117.69K |
Oct 15
| |||
Form 4
|
—
|
0
|
$63.63 | -$15,274.50 | 114.82K |
Sep 25
| |||
Form 4
|
—
|
0
|
$63.36 | -$24,492.86 | 114.82K |
Sep 20
| |||
Form 4
|
—
|
0
|
$62.38 | -$16,970.25 | 114.82K |
Sep 13
| |||
Form 4
| -0.31% | -352.00 |
$66.62 | -$23,451.30 | 114.82K |
Jul 30
| |||
Form 4
|
—
|
0
|
$54.07 | -$982,856.10 | 115.17K |
Jul 27
| |||
Form 4
| +0.97% | 1.1K |
$56.99 | -$16,112.18 | 115.17K |
Jul 23
| |||
Form 4
| -100.00% | -824.00 |
$60.22 | -$49,622.18 |
0
|
Mar 20
| |||
Form 4
| -4.92% | -5.91K |
$57.00 | -$574,113.17 | 114.07K |
Feb 29
| |||
Form 4
| +28.63% | 26.7K |
—
|
—
| 119.97K |
Feb 17
| |||
Form 4
|
—
|
0
|
$54.32 | -$6,582.12 | 93.27K |
Dec 21
| |||
Form 4
| +3.17% | 2.87K |
$52.73 | -$107,147.36 | 93.27K |
Oct 15
| |||
Form 4
| -8.01% | -7.87K |
$47.87 | -$711,647.86 | 90.41K |
Feb 28
| |||
Form 4
| +49.41% | 32.5K |
—
|
—
| 98.27K |
Feb 18
| |||
Form 4
| -4.22% | -2.90K |
$45.27 | -$131,288.80 | 65.77K |
Feb 1
| |||
Form 4
| +4.51% | 2.97K |
$53.21 | -$102,908.14 | 68.67K |
Oct 15
| |||
Form 4
| -9.94% | -7.25K |
$54.35 | -$933,983.98 | 65.71K |
Feb 26 - Mar 1
| |||
Form 4
| +157.27% | 44.6K |
—
|
—
| 72.96K |
Feb 19
| |||
Form 4/A
| -14.34% | -4.75K |
$53.93 | -$256,127.97 | 28.36K |
Feb 16
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +34.35% | 7.25K |
$53.93 | -$256,127.97 | 28.36K |
Feb 16
| |||
Form 4
|
—
|
0
|
$51.22 | -$7,109.52 | 21.11K |
Feb 10
| |||
Form 4
| -19.15% | -5.00K |
$50.95 | -$254,758.00 | 21.11K |
Nov 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AbbVie Inc. (ABBV) Snapshot price: $193.15
Vice Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$67.94 | -$7,427,019.60 | 114.9K |
Nov 16
| |||
Form 4
| -31.70% | -53.33K |
$100.00 | -$5,332,554.58 | 114.9K |
Jul 7
| |||
Form 4
| -16.02% | -32.09K |
$85.42 | -$2,741,298.64 | 168.22K |
Feb 28
| |||
Form 4
| +56.65% | 72.44K |
—
|
—
| 200.32K |
Feb 20
| |||
Form 4
| -15.87% | -24.13K |
$79.41 | -$1,915,766.25 | 127.88K |
Feb 28
| |||
Form 4
| +55.82% | 54.45K |
—
|
—
| 152K |
Feb 21
| |||
Form 4
| -38.65% | -61.45K |
$72.31 | -$11,234,863.73 | 97.55K |
Feb 28 - Mar 1
| |||
Form 4
| +18.16% | 44.26K |
—
|
—
| 287.95K |
Feb 15
| |||
Form 4
|
—
|
0
|
$47.11 | -$2,097,264.44 | 114.75K |
Jun 14
| |||
Form 4
| -27.26% | -43.00K |
$67.00 | -$2,881,000.00 | 114.75K |
May 4
| |||
Form 4
| -18.04% | -34.72K |
$62.22 | -$2,160,340.62 | 157.75K |
Feb 28
| |||
Form 4
| +28.79% | 43.02K |
—
|
—
| 192.47K |
Feb 16
| |||
Form 4
| -24.09% | -47.44K |
$63.52 | -$3,013,261.76 | 149.44K |
May 10
| |||
Form 4
| -16.86% | -39.93K |
$56.00 | -$2,236,080.00 | 196.88K |
Feb 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 18
| |||
Form 4
| -7.75% | -19.91K |
$60.51 | -$1,204,567.12 | 236.81K |
Feb 27 - Feb 28
| |||
Form 4
| +25.14% | 51.58K |
—
|
—
| 256.72K |
Feb 19
| |||
Form 4
| -8.15% | -18.20K |
$50.78 | -$924,246.07 | 205.14K |
Feb 28 - Mar 3
| |||
Form 4
| +26.84% | 47.26K |
—
|
—
| 223.34K |
Feb 20
| |||
Form 4
| +19.92% | 29.24K |
$36.82 | -$1,197,336.50 | 176.08K |
May 1
| |||
Form 4
| -8.11% | -12.96K |
$36.73 | -$476,020.80 | 146.84K |
Feb 28
| |||
Form 4
| +41.51% | 46.87K |
$37.58 | -$369,261.08 | 159.79K |
Feb 14 - Feb 19
| |||
Form 4
| +0.14% | 157 |
$35.54 | -$2,789.36 | 112.92K |
Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SpringWorks Therapeutics, Inc. (SWTX) Snapshot price: $38.75
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +27.85% | 4.09K |
—
|
—
| 18.8K |
May 16
| |||
Form 4
| +46.21% | 4.65K |
—
|
—
| 14.71K |
May 24
| |||
Form 4
|
∞
| 10.06K |
—
|
—
| 10.06K |
Jul 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solventum Corp No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||